Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

thinkemotive

- PMLiVE

FDA wants more data on J&J’s arthritis drug Plivensia

Requests further evidence on the drug’s safety profile after patient deaths link

- PMLiVE

Prof Sir Mike Richards joins Incisive Health as senior counsel

He recently stepped down as chief inspector of hospitals

AI’s potential in the pharma life cycle

At a time that the future of life sciences is being hotly debated, the opportunity for the industry to refine and expand its role is an important one to take...

- PMLiVE

Dr Paula Salmikangas joins NDA Group

Moves to the regulatory affairs consultancy from the Finnish Medicines Agency

- PMLiVE

And breathe…

…or, why there is no ‘fast track’  to communications excellence

- PMLiVE

Humanisation

The key to delivering communications excellence

- PMLiVE

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Germany and the UK will be the first to receive the skin cancer treatment

- PMLiVE

Intercept hit hard as FDA issues Ocaliva safety notice

The PBC treatment has been linked to 19 deaths and 11 cases of liver damage

- PMLiVE

Translation company Conversis appoints Jamie Newall as CEO

He will also sit on the UK firm's board

- PMLiVE

Former GSK CEO joins Synthego’s advisory board

Sir Andrew Witty will expand the team’s bioinformatics expertise

- PMLiVE

Attracting doctors to low-demand specialties

A role for industry?

- PMLiVE

Signal strength

Communications that connect

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links